Non-small cell lung cancer. Review uri icon

Overview

abstract

  • Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer. These guidelines only include information about stage IV NSCLC. Patients with widespread metastatic disease (stage IV) are candidates for systemic therapy, clinical trials, and/or palliative treatment. The goal is to identify patients with metastatic disease before initiating aggressive treatment, thus sparing these patients from unnecessary futile treatment. If metastatic disease is discovered during surgery, then extensive surgery is often aborted. Decisions about treatment should be based on multidisciplinary discussion.

authors

publication date

  • October 1, 2012

Research

keywords

  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Medical Oncology

Identity

Scopus Document Identifier

  • 84870996017

PubMed ID

  • 23054877

Additional Document Info

volume

  • 10

issue

  • 10